NOVADEL PHARMA INC filed this SB-2/A on 11/12/1997.
« Prev Page	Outline	Printer Friendly	Entire Filing	Next Page »

   
                                             
 5.1     -        (3)Opinion of Reed Smith Shaw & McClay LLP
10.1     -        (2)Employment Agreement with Harry A. Dugger, III, Ph.D.
10.2     -        (3)Employment Agreement with John J. Moroney
10.3     -        (2)Agreement dated December 7, 1996 between the Registrant and Altana, Inc.
10.4     -        (2)Agreement dated December 19, 1996 between the Registrant and Sandoz
                     Pharmaceuticals
10.5     -        (2)Registrant's 1992 Stock Option Plan
10.6     -        (3)Form of Option Agreement under 1992 Stock Option Plan
10.7     -        (2)Registrant's 1997 Stock Option Plan
10.8     -        (3)Form of Option Agreement under 1997 Stock Option Plan
10.9     -        (2)Agreement with Rapid Spray (Clemastine) dated June 2, 1992
10.10    -        (2)Agreement with Rapid Spray (Nitroglycerin) dated June 2, 1992
10.11             (3)Agreement with Creative Technologies, Inc. dated December 26, 1996
11.1     -        (3)Computation of earnings per share
23.1     -        (1)Consent of Wiss & Company, LLP (included on page II-7)
23.2     -        (3)Consent of Reed Smith Shaw & McClay LLP (included in Exhibit 5.1)
27.1     -        (3)Financial Data Schedule - Fiscal Years Ended 1996 and 1997

(1)  Filed herewith.

(2)  Filed as an exhibit to the Registration Statement (No. 333-33201)
     on August 8, 1997.

(3)  Filed as an exhibit to Amendment No. 1 to the Registration Statement 
     (No. 333-33201) on October 3, 1997.

(4)  Filed as an exhibit to Amendment No. 2 to the Registration Statement
     (No. 333-33201) on October 31, 1997.

    
Item 28.  Undertakings.

         The undersigned Registrant hereby undertakes:

         (1) To file, during any period in which offers or sales are being made,
a post-effective amendment to this Registration Statement:

                  (i) To include any prospectus required by Section 10(a)(3)
         of the Act;

                  (ii) To reflect in the prospectus any facts or events arising
         after the effective date of the Registration Statement (or the most
         recent post-effective amendment thereof) which, individually or in the
         aggregate, represent a fundamental change in the information set forth
         in the Registration Statement;

                  (iii) To include any material information with respect to the
         plan of distribution not previously disclosed in the Registration
         Statement or any material change to such information in the
         Registration Statement; and

                                      II-4